Background: Increased serum activity of CK isoenzymes and macroenzymes, and in particular of the brain isoenzyme (CK-BB) has been reported in dogs with central nervous system (CNS) disorders. However, no studies on the possible differences in serum activities of CK iso-or macroenzymes (Macro-CK1 and Macro-CK2) in different neurologic diseases are available. Objective: The aim of this study was to describe the electrophoretic distribution of CK iso-and macroenzymes in dogs with CNS disorders in order to assess whether this distribution depends on a specific neurologic disease. Methods: This study was done on sera from 45 dogs with neurologic diseases (degenerative, n = 7; idiopathic epilepsy [IE], n = 14; inflammatory, n = 16; space occupying lesions [SOL], n = 8) and from 10 clinically healthy dogs. The separation of serum CK isoenzymes and macroenzymes was performed using an automated electrophoretic method already validated in dogs. Results: Compared with healthy dogs, dogs with CNS disorders had significantly higher total CK and CK-BB activities, and a significantly lower Macro-CK2 activity (P < .001). Comparison of pathologic subgroups and healthy dogs revealed significant differences (P < .01) in dogs with IE and inflammatory disorders for total CK activity, in all the subgroups for CK-BB (P < .01), and in dogs with IE and SOL for Macro-CK2 (P < .01).
Introduction
Creatine kinase (CK; EC 2.7.3.2) catalyzes the reversible reaction between adenosine diphosphate (ADP) and phosphocreatine to form creatine and ATP. In most species, tissues with high CK activity include skeletal and cardiac muscle, followed by neural tissue. 1 The leakage of CK from injured tissues leads to increased CK activity in blood. Therefore, an increase in plasma or serum CK activity may be a biomarker of tissue damage. Creatine kinase is composed of 2 monomers, B and M. 2 Combinations of these monomers generate the 3 isoenzymes CK-BB, CK-MB, and CK-MM, which are found predominantly in brain, heart, and skeletal muscle, respectively. [3] [4] [5] A small amount of CK-BB may also be produced in intestine and spleen. 5 In addition to the 3 dimeric isoenzymes, there is a structurally different mitochondrial isoform, CK-MT or CKm, detectable in tissues, and 2 macroenzymes, the macro-CK1 and the macro-CK2, detectable in blood. Macro-CK1 is formed by the dimeric CK-BB Dr. Paltrinieri, an editor of the journal, was not involved in the peer-review process or the decision to publish this article.
bound to the immunoglobulins circulating in the bloodstream, while macro-CK2 consists of oligomers of CK-MT. 3, 6 The activities of these 2 macroenzymes increase in immune-mediated and neoplastic conditions in people 6 , but are present in variable proportion in the blood of clinically healthy dogs. 4 Total CK activity can be measured in plasma utilizing CK-N-acetylcysteine (CK-NAC) as an activator. 7 Total CK activity mainly reflects CK-MM activity, which accounts for the majority of plasma CK activity in many species. 8 The CK-MB isoenzyme that may be used to diagnose or stage myocardial disease in people and in some animal species is usually measured using immunoenzymatic methods. 9 Conversely, most of the methods to determine the activity of CK-BB and macroenzymes are laborious or expensive. 3 Nevertheless, electrophoretic separation has been shown to be a reliable method to identify and quantify CK-BB and macroenzymes in many species. 4, 10, 11 Due to its prevalent production within the central nervous system (CNS), CK-BB may provide information about CNS lesions. Serum CK-BB activity in dogs with CNS disease was so far investigated in a previous study using a combined immunosubtraction/electrophoretic method. 12 Recently, a preliminary study based on electrophoretic fractionation 4 demonstrated increased serum CK-BB activity in 3 dogs with CNS signs. Unfortunately, no confirmed final diagnoses were provided on the dogs included in the study and it was impossible to correlate the neurologic condition with the magnitude of CK-BB activity increase.
The hypothesis of this study was that the type of CNS disorder may influence the magnitude of change in CK isoenzyme or macroenzyme activity in serum, as the degree of neuronal damage is expected to be more extensive in inflammatory or degenerative lesions than in functional lesions (eg, idiopathic epilepsy [IE]) or in the presence of space occupying lesions (SOL). Therefore, the aim of this study was to describe the electrophoretic distribution of CK isoenzymes and macroenzymes in serum of dogs with central neurologic disorders, grouped according to disease categories (degenerative, idiopathic, inflammatory, SOL) in order to assess whether increases of total CK, CK iso-, and macroenzymes in serum depend on a specific CNS disease.
Materials and Methods
Medical records of dogs with CNS signs referred to the Portoni Rossi Veterinary Hospital, Zola Predosa, Italy, were reviewed periodically to select the samples to be used in this study over a 3-year period (January 2009-December 2012). Inclusion in this study required (1) documentation of a complete neurologic examination on presentation; (2) availability of magnetic resonance imaging (MRI) of either the brain or spinal cord; (3) analysis of cerebrospinal fluid (CSF) collected from either cerebellomedullary or lumbar cistern, including macroscopic evaluation, total nucleated cell count, total protein concentration, and cytologic evaluation; (4) laboratory data including a CBC, a basic panel of serum biochemical analytes (including urea, creatinine, glucose, total proteins, albumin, ALP, ALT, LDH, GGT, calcium, phosphorus, serum protein electrophoresis, and urinalysis); and (5) a final confirmed diagnosis of IE, SOL, and inflammatory or degenerative disease. The diagnosis of IE was based on unremarkable results of physical and neurologic examinations, hematologic and serum biochemical analyses, brain MRI, and CSF analysis. The diagnosis of SOL was based on the detection of intra-or extra-axial masses in the MRI in dogs with normal CSF findings, including compression by infiltrative lesions. Diagnosis of inflammatory conditions was based on course of disease, multifocal CNS signs, inflammatory CSF (protein content > 25 mg/dL, nucleated cell count > 5/lL) 13 , and MRI features suggestive of an inflammatory disease, supported by other positive tests for infectious disease. Degenerative conditions were diagnosed either presumptively on the basis of history, signalment, MRI features, and a normal CSF, or in one case, on the basis of postmortem histopathology findings.
Exclusion criteria were grossly hemolyzed or lipemic samples, and dogs with clinical and/or laboratory changes consistent with metabolic disease potentially responsible for secondary neurologic signs. A group of 10 clinically healthy dogs based on a routine physical and neurologic examination during the same period were selected as control dogs. One additional criterion in the control group was the absence of any laboratory abnormality, including a serum total CK activity < 150 U/L, the upper limit of the RI determined in our laboratory on a population of 80 clinically healthy dogs following the ASVCP guidelines for the establishment of RI.
14 All dogs were client-owned and sampled for diagnostic purposes or during routine wellness examination. Venous blood samples were collected into vacutainer plain tubes (Venoject, Terumo Italia Srl, Rome, Italy). Serum was obtained by centrifugation (1100g for 8 min). After collection and separation of serum, total CK activity was measured using the CK-NAC method and an automated spectrophotometer (Cobas Mira, Roche Diagnostic, Basel, Switzerland) with reagents from Real-Time Diagnostic System (Viterbo, Italy). The CK-NAC method contains reducing agents such as N-acetyl cysteine that restores the loss of CK activity due to reversible oxidation of the enzyme during storage. 4 Samples were stored at À20°C until electrophoretic analyses were performed.
The electrophoretic separation of CK isoenzymes and macroenzymes was performed within one month from sampling in healthy dogs, and on 40 of 45 dogs with CNS signs. Five samples were used to determine total CK activity only as the available serum was not sufficient to perform the electrophoretic separation of isoenzymes. A commercially available kit (Hydragel ISO-CK; Sebia Italia, Florence, Italy) and an automated apparatus (Hydrasys; Sebia Italia) equipped with specific accessories (Standard Mask Accessories for ISO-CK/ LD) were used, following the manufacturer's instructions, modified as described in a previous study. 4 With each run, a mixture of homogenized canine brain, and cardiac and skeletal muscle was used as a positive control. Briefly, 200 lL of serum or tissue homogenate were mixed with 2 lL of the activating solution containing b-mercaptoethanol, and were incubated for 10 min at room temperature. Twenty lL of this mixture were placed in the applicator. The gel included in the kit (agarose 8%, pH 8.40 AE 0.05) and the applicator were placed in the migration chamber and the automatic migration program was then selected (10-20 W, 27 Vh, 20°C). The resulting CK bands were visualized by adding CK substrate and the chromogen solution. After stopping the reaction with blocking solution, gels were washed, dried by heating, and scanned. Scanned images were then analyzed using a specific software (Phoresis; Sebia Italia) and visual inspection in order to identify and correct possible fractionation errors performed by the software.
Intra-and inter-assay CV or imprecision, as assessed in a previous study 4 , ranged from 1.4% to 2.9% for the most abundant macro-or isoenzymes (CK-MM, CK-BB, Macro-CK2), and were slightly higher for CK-MB (intra-assay CV = 3.8%; inter-assay CV = 9.4%) and macro-CK1 (7.4% and 12.0%, respectively), each of which accounted for less than 2% of total CK activity.
Statistical analyses were done using an Excel spreadsheet (Microsoft Corp, Redmond, WA, USA) and Analyse-it software (Analyse-it Software Ltd., Leeds, UK). Results from the whole group of dogs with central neurologic disease were compared with those of the healthy animals using a Mann-Whitney U test. Then, results from healthy dogs and from each subgroup of dogs with CNS disease were compared to each other using a nonparametric ANOVA test (Kruskal- The 10 healthy dogs included 6 males and 4 females, had an age range from 1 to 12 years (median 7 years), and included 3 mixed-breed dogs (30%) and 7 (70%) purebred dogs (2 German Shepherd dogs, 2 Labrador Retrievers, one each English Setter and Standard Schnauzer).
Distribution of CK electrophoretic fractions in serum
Electrophoretic fractionation of CK iso-and macroenzymes using the modified method employed in this study resulted in clearly separated bands on the gels (Figure 1 ) translating into distinct and narrow peaks in the scanned tracings ( Figure 2 , Table 2 ). The activities of total and fractionated CK of healthy dogs were similar to those recorded in a previous study. 4 The predominant electrophoretic fraction was CK-MM, followed by macro-CK2 and CK-BB, while CK-MB and macro-CK1 were virtually absent. Compared with results of healthy dogs, the whole group of dogs with CNS disorders had significantly higher total serum CK and CK-BB activities, and a significantly lower Macro-CK2 activity. No statistically significant differences were found for CK-MB, Macro-CK1, or CK-MM activity; however, there was a high inter-individual variability.
Comparison of pathologic subgroups and healthy dogs revealed significant differences in dogs with IE and inflammatory disorders for total CK activity, in all the subgroups for CK-BB, and in dogs with IE and SOL for Figure 1 . Electrophoretic gel of homogenized normal canine tissue, including brain, cardiac, and skeletal muscle used as a control material (C), serum from a clinically healthy dog (H), and sera from dogs with degenerative neurologic disease (D), idiopathic epilepsy (IE), inflammation (I), and a space occupying lesion (SOL).
Figure 2. Example of electrophoretograms obtained in a clinically healthy dog (H) and in dogs with neurologic diseases classified as degenerative (D), idiopathic epilepsy (IE), inflammation (I), and space occupying lesions (SOL).
Macro-CK2. The individual variability was high in all the pathologic subgroups ( Figure 3 ).
Discussion
The results of this study were consistent with those obtained in a previous study. 4 Specifically, despite the low number of dogs and the relative heterogeneity of the pathologic subgroups, significantly increased CK isoenzyme activities, especially CK-BB, were identified in dogs with CNS diseases. In almost all cases, the magnitude of these increases was higher than the intrinsic analytic variability of the method previously reported 4 , supporting the hypothesis that the observed increases were related to the pathologic conditions and not to the analytic imprecision of the method.
Furthermore, this study demonstrates that the increase of total CK activity in dogs with CNS disease does not depend on the release of CK-MM from muscle cells (eg, due to convulsions or prolonged recumbency) as postulated in the past. 5, 8 Rather, the release of CK-MM from skeletal muscle and, to a lesser extent, of CK-MB from myocardium, is probably only contributing to the increased total CK activity. However, the high inter-individual variability, likely related to the different degree of neurologic signs potentially affecting muscle functions caused these differences to be statistically insignificant. In this context, the relatively small number of dogs and the heterogeneous group composition are considered a limitation of the present study, and future studies should include larger numbers of dogs. However, the higher median value of CK-MM in dogs with CNS inflammation may in part be due to the muscle activity associated to seizures (eg, meningoencephalitis of unknown origin) or to muscle contracture associated with cervical pain (eg, steroid responsive meningitis-arteritis) that are more frequent and severe in inflammatory conditions than in other CNS diseases, as excessive muscle contraction may induce lesions to the cell membranes and results in subsequent leakage of intracytoplasmic CK. 5 We postulate that a similar mechanism may explain the increase in CK-MB or macro-CK2 activity in dogs with inflammation although not significant in this study, as oligomers of mitochondrial CK may be released when cell damage induced by muscle contraction is particularly severe. Conversely, the increase of Macro-CK1 may be a consequence of the increase of CK-BB, as Macro-CK1 is a dimer between CK-BB and the antibodies present in serum. In contrast, in all other subgroups except the inflammatory group, macro-CK2 was lower, although the biologic relevance of this decrease remains unclear. ANOVA (healthy vs pathological subgroups) = P < .01. *P < .05 compared with healthy dogs. **P < .01 compared with healthy dogs. ***P < .001 compared with healthy dogs. There was a consistent increase of CK-BB activity in all sick dogs. In human adults, CK-BB is mainly expressed in brain. 4, 15 The increased serum CK-BB activity in dogs with CNS diseases may depend either on the release of this isoenzyme from the cytoplasm of neurons or a damage of the blood-brain barrier. This is not surprising in inflammatory disorders, where cell damage due to inflammatory mediators may induce the leakage of intracytoplasmic enzymes. 8 Theoretically, permeabilization of cell membranes could be responsible for the leakage of CK-BB from neurons also in degenerative conditions and in dogs with SOL, as hypoxic conditions potentially associated with compression exerted by masses may induce permeabilization of cell membranes, similar to transaminase leakage from damaged hepatocytes in the liver. 8 However, this seems to represent an inconsistent observation, as CK-BB was increased only in 2/3 of the dogs with SOL (4 dogs out of 6). It would be interesting to verify a correlation of magnitude of CK-BB activity increase with different types of inflammation (eg, infectious vs immune-mediated), degenerative diseases or SOL. This was impossible in the present study, as the number of dogs per subgroup was too small to perform a reliable statistical comparison. Regarding SOL, in this study, histologic diagnosis was available only for 3 of 4 extra-axial masses, and none for intraaxial SOL. Therefore, a statistical comparison was impossible, either due to the lack of a definite histologic diagnosis or to the low number of cases per subgroup. However, in future studies, it would be interesting to compare the results of dogs with confirmed histologic diagnoses for both intra-and extraaxial SOL. This comparison may be important as it is likely that the magnitude of change in total or fractionated CK may be influenced by the type and location of a tumor. Similarly, it would be interesting to assess the changes in the activity of CK iso-and macroenzymes in dogs with different degenerative conditions. To this aim, it would be necessary to achieve a final histologic diagnosis, as in the current study, the diagnosis of degenerative conditions was based on signalment, history, and laboratory investigation, and the exclusion of other diseases. Although, based on this information, it is very unlikely that dogs included in this disease category were not affected by degenerative disorders, a definitive histologic diagnosis would strengthen a possible correlation of the results with defined and confirmed degenerative conditions.
The increase of serum CK-BB activity in dogs with IE is surprising, as this condition should be characterized by alterations of neuronal functions in the absence of morphologic abnormality 16 and leakage of CK-BB from neurons would not be expected. It is possible that transient changes of neuronal permeability or alterations in membrane transporters or receptors not detectable with routine diagnostic imaging or histopathology may induce the leakage of intracellular enzymes. It is also possible that some of these dogs suffered from status epilepticus (SE), characterized by definition by seizures lasting > 5 minutes or by a series of at least 2 discrete seizures without full recovery of consciousness between the seizures. 17 Continuous seizure activity of 30 minutes or longer may cause systemic dysfunction, including hypoxia, altered blood pressure, and hyperthermia, and can lead to temporary or permanent brain lesions. 16 Unfortunately, in this study, it was not possible to standardize the time between the first appearance of clinical IE signs and the time of blood sampling, as samples were collected during the routine diagnostic activity in a referral center for neurologic diseases. In future studies, it would be interesting to investigate whether the increase of CK-BB activity in serum of dogs with IE depends on the presence and severity of SE.
Independent of the mechanisms responsible for the increase of CK-BB activity, this may represent a useful marker to confirm a diagnosis of CNS disease. However, the general CK-BB activity increase in all the pathologic subgroups included in this study did not allow a diagnostic differentiation. Theoretically, the multiple abnormalities in CK iso-and macroenzymes (simultaneous increase of CK-BB, CK-MM, Macro-CK1) could suggest an inflammatory disease as the magnitude of these increases was often very high, albeit not statistically significantly different from other disease groups. Therefore, an increase of one or a combination of these variables above a given threshold may support a clinical diagnosis of an inflammatory CNS disorder. However, an appropriate statistical approach 18 was not possible in the present study as nonneurologic conditions characterized by increases of one or more isoenzymes (eg, myopathy, cardiomyopathy, muscular, or neurologic damage secondary to a series of primary pathological conditions, etc.) were not included. Therefore, the diagnostic specificity would be falsely high. However, this aspect merits further investigation in the future.
Additionally, it would be important to determine the diagnostic sensitivity of changes in total and fractioned CK iso-and macroenzymes as the data of our study were overlapping between sick and healthy dogs within the RI of the laboratory. The better understanding of such false-negative results would provide a more adequate assessment of the diagnostic accuracy of increased total and fractioned CK iso-and macroenzymes. This includes an assessment of the diagnostic significance of increased CK-BB activity in CSF.
In this study, no CK activity was recorded in 4 frozen and thawed CSF samples, and the electrophoretic separation of iso-or macroenzymes did not reveal visible bands on these samples (S.P., unpublished results). This was considered a storage artifact as many enzyme activities vanish rapidly in frozen CSF 19 , while the negative effect of freezing and thawing on serum samples is negligible. 20 In conclusion, despite some limitations such as the low number of animals per group and the wide individual variability, this study demonstrates that many CK isoenzymes, including CK-BB, increase in serum of dogs with CNS disease. This increase seems to be independent on the type of disease, but is likely due to the leakage from neurons affected by inflammatory or degenerative conditions, or to the hypoxia associated with SOL. The mechanism responsible for increases of CK-BB in dogs with IE remains to be elucidated. From a diagnostic standpoint, the measurement of total CK and CK iso-or macroenzymes (with special emphasis on CK-BB) in serum may be useful to confirm suspected CNS disease in cases with a suspicious clinical presentation. However, further diagnostic testing such as diagnostic imaging or CSF analysis is still necessary for a specific diagnosis.
Additionally, future studies should include dogs with nonneurologic disease that are accompanied by increased total CK in order to assess the diagnostic specificity of CK-BB activity increase.
